Auna S.A. (NYSE:AUNA – Get Free Report) President Leon Jesus Zamora bought 30,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were purchased at an average price of $4.39 per share, with a total value of $131,700.00. Following the completion of the acquisition, the president directly owned 45,914 shares in the company, valued at $201,562.46. This trade represents a 188.51% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Leon Jesus Zamora also recently made the following trade(s):
- On Friday, May 29th, Leon Jesus Zamora purchased 6,420 shares of Auna stock. The stock was bought at an average cost of $4.15 per share, for a total transaction of $26,643.00.
- On Thursday, May 28th, Leon Jesus Zamora purchased 9,220 shares of Auna stock. The stock was bought at an average cost of $4.17 per share, for a total transaction of $38,447.40.
- On Wednesday, May 20th, Leon Jesus Zamora purchased 5,814 shares of Auna stock. The stock was bought at an average cost of $4.39 per share, for a total transaction of $25,523.46.
- On Wednesday, May 27th, Leon Jesus Zamora purchased 23,273 shares of Auna stock. The stock was bought at an average cost of $4.20 per share, for a total transaction of $97,746.60.
- On Tuesday, May 26th, Leon Jesus Zamora purchased 8,727 shares of Auna stock. The stock was bought at an average cost of $4.24 per share, for a total transaction of $37,002.48.
Auna Price Performance
AUNA stock opened at $4.54 on Tuesday. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. The firm has a market capitalization of $336.01 million, a P/E ratio of 17.46 and a beta of 0.82. The business’s 50-day moving average is $5.20 and its two-hundred day moving average is $5.01. Auna S.A. has a 1 year low of $4.09 and a 1 year high of $6.85.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on AUNA. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research report on Friday, March 27th. JPMorgan Chase & Co. reduced their price target on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Zacks Research lowered Auna from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. Finally, Wall Street Zen lowered Auna from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 16th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $6.97.
View Our Latest Research Report on AUNA
Institutional Investors Weigh In On Auna
Hedge funds and other institutional investors have recently made changes to their positions in the business. World Investment Advisors acquired a new stake in shares of Auna during the 4th quarter worth about $52,000. Virtu Financial LLC acquired a new position in Auna during the third quarter worth approximately $75,000. Millennium Management LLC acquired a new position in Auna during the third quarter worth approximately $83,000. Clear Harbor Asset Management LLC acquired a new position in Auna during the fourth quarter worth approximately $63,000. Finally, Sanctuary Advisors LLC acquired a new position in Auna during the first quarter worth approximately $71,000.
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Recommended Stories
- Five stocks we like better than Auna
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
